Baseline Characteristics | Total (n = 179) | ICP group (n = 89) | ICPpD group (n = 90) | P Value |
---|---|---|---|---|
Demographics | ||||
 Age, mean (SD), y | 62.2 ± 13.0 | 61.9 ± 13.2 | 62.5 ± 12.8 | 0.766 |
 Male | 129(72.1) | 62(69.7) | 67(74.4) | 0.173 |
 Female | 50(27.9) | 27(30.3) | 23(25.6) | 0.283 |
 BMI, mean (SD), kg/m2 | 24.98(3.07) | 24.26(3.31) | 25.57(3.82) | 0.124 |
 Weight, mean (SD), kg | 68.99 ± 10.89 | 67.91 ± 12.21 | 70.32 ± 8.10 | 0.349 |
Presenting characteristics, mean (SD) | ||||
 Heart rate, beat/min | 82.56 ± 15.52 | 75.4 ± 12.54 | 91.5 ± 15.503 | 0.128 |
 Systolic blood pressure, mmHg | 123.7 ± 22.84 | 120 ± 27.009 | 128.25 ± 19.19 | 0.624 |
Medical history | ||||
 Hypertension | 81 (45.3) | 38 (42.7) | 43 (47.8) | 0.531 |
 Hypercholesterolemia | 51 (28.5) | 27 (30.3) | 24 (26.7) | 0.323 |
 Diabetes mellitus | 21 (11.7) | 10 (11.2) | 11 (12.2) | 0.317 |
 Atrial fibrillation | 11 (6.2) | 6 (6.7) | 5 (5.6) | 0.673 |
 Renal impairment | 7 (3.9) | 3 (3.4) | 4 (4.4) | 0.783 |
Smoking | ||||
 Current | 67 (37.4) | 35 (39.3) | 32 (35.6) | 0.364 |
 Former (stopped > 3 mo) | 16 (39.3) | 9 (10.1) | 7 (7.8) | 0.247 |
 Never | 96 (53.6) | 45 (50.6) | 51 (56.7) | 0.155 |
Preexisting maintenance medication | ||||
 Aspirin | 32 (17.9) | 15 (16.9) | 17 (18.9) | 0.754 |
 Statin | 60 (33.5) | 31 (34.8) | 29 (32.2) | 0.813 |
 β-blocker | 66 (36.9) | 34 (38.2) | 32 (35.6) | 0.471 |
 ACE inhibitor/ARB | 54 (30.2) | 25 (28.1) | 29 (32.2) | 0.542 |
Killip class | ||||
 I | 158 (88.3) | 77 (86.5) | 81 (90.0) | 0.267 |
 II‒IV | 21 (11.7) | 12 (13.5) | 9 (10.0) | 0.361 |
TIMI risk score | ||||
 Low risk (0–3) | 32 (17.9) | 15 (16.9) | 17 (18.9) | 0.383 |
 Moderate risk (4–6) | 115 (64.3) | 56 (62.9) | 59 (65.6) | 0.186 |
 High risk (7–14) | 32 (17.9) | 18 (20.2) | 14 (15.6) | 0.369 |
Initial blood results on admission | ||||
 Glucose, mean (SD), mmol/L | 7.50 ± 3.19 | 7.73 ± 3.46 | 7.27 ± 2.90 | 0.343 |
 Creatinine, mean (SD), μmol/L | 75.71 ± 25.53 | 75.25 ± 26.29 | 76.17 ± 24.91 | 0.809 |
 Uric acid, mean (SD), μmol/L | 365.00 ± 110.60 | 355.64 ± 99.66 | 374.25 ± 120.362 | 0.262 |
 Total cholesterol, mean (SD), mmol/L | 4.981 ± 1.33 | 5.10 ± 1.34 | 4.86 ± 1.32 | 0.235 |
 Triglycerides, mean (SD), mmol/L | 1.84 ± 2.10 | 1.57 ± 1.19 | 2.10 ± 2.69 | 0.089 |
 HDL-C, mean (SD), mmol/L | 1.26 ± 0.30 | 1.31 ± 0.32 | 1.21 ± 0.28 | 0.022 |
 LDL-C, mean (SD), mmol/L | 3.15 ± 1.06 | 3.24 ± 1.11 | 3.07 ± 1.01 | 0.279 |
 Creatine kinase isoenzyme, mean (SD), IU/L | 190.60 ± 137.50 | 182.94 ± 138.52 | 198.56 ± 136.85 | 0.467 |
 Troponin I, median (IQR), ng/mL | 4882.00 ± 13,801.00 | 6562.34 ± 16,067.71 | 4161.18 ± 13,312.99 | 0.732 |
 Platelet count, mean (SD), × 109/L | 215.90 ± 62.14 | 214.47 ± 52.02 | 217.35 ± 71.18 | 0.782 |
 Mean platelet volume, mean (SD), fL | 10.93 ± 1.23 | 10.85 ± 1.10 | 11.00 ± 1.36 | 0.459 |
 Leukocyte count, mean (SD), × 109/L | 10.90 ± 3.28 | 11.00 ± 3.38 | 10.80 ± 3.20 | 0.717 |
 Neutrophil count, mean (SD), × 109/L | 8.64 ± 3.25 | 8.76 ± 3.36 | 8.52 ± 3.16 | 0.653 |
 Lymphocyte percentage, mean (SD), % | 13.9 ± 7.1 | 13.9 ± 7.0 | 13.9 ± 7.4 | 0.967 |
 Neutrophil, mean (SD), % | 77.7 ± 9.4 | 78.1 ± 9.1 | 77.2 ± 9.8 | 0.579 |
 Monocyte, mean (SD), % | 7.7 ± 3.3 | 7.3 ± 3.3 | 8.1 ± 3.3 | 0.132 |
 Eosinophil, mean (SD), % | 0.7 ± 0.1 | 0.7 ± 1.0 | 0.7 ± 1.1 | 0.703 |
 Basophil, mean (SD), % | 0.2 ± 0.1 | 0.2 ± 0.1 | 0.2 ± 0.2 | 0.309 |